Publikationen, an denen er mitarbeitet MARIA TERESA BOBES BASCARAN (19)

2022

  1. El programa multicomponente de apoyo para el cese del tabaquismo (McSCSP) es efectivo en pacientes con trastorno mental grave sin diferencias de género

    Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 3, pp. 218-226

  2. Results of the COVID-19 mental health international for the general population (COMET-G) study

    European Neuropsychopharmacology, Vol. 54, pp. 21-40

  3. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 22-28

  4. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 14-21

2021

  1. Are older adults also at higher psychological risk from COVID-19?

    Aging and Mental Health, Vol. 25, Núm. 7, pp. 1297-1304

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms

    Frontiers in Psychiatry, Vol. 12

  4. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia

    Psicothema, Vol. 33, Núm. 3, pp. 473-480

2020

  1. Early Psychological Correlates Associated With COVID-19 in A Spanish Older Adult Sample

    American Journal of Geriatric Psychiatry, Vol. 28, Núm. 12, pp. 1287-1298

  2. Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample

    Journal of global health, Vol. 10, Núm. 2, pp. 020505

  3. Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample

    The Journal of clinical psychiatry, Vol. 81, Núm. 6

2019

  1. Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 116-129

  2. Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology

    Psychiatry Research, Vol. 280

2018

  1. Validación española de la escala de evaluación de los síntomas negativos-16 (NSA-16) en pacientes con esquizofrenia

    Revista de Psiquiatría y Salud Mental, Vol. 11, Núm. 3, pp. 169-175

2016

  1. A review of quality-of-life assessment measures in schizophrenia: Limitations and future developments

    Beyond Assessment of Quality of Life in Schizophrenia (Springer International Publishing), pp. 65-77

  2. It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline

    Schizophrenia Research, Vol. 176, Núm. 2-3, pp. 272-280

  3. Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI)

    International journal of clinical and health psychology, Vol. 16, Núm. 1, pp. 58-75

2015

  1. Predictive factors of functional capacity and real-world functioning in patients with schizophrenia

    European Psychiatry, Vol. 30, Núm. 5, pp. 622-627

  2. Psychometric evaluation of the negative syndrome of schizophrenia

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, Núm. 7, pp. 559-566